IL15 and Miyoshi myopathy: In this study, we performed comprehensive preclinical characterization of AlloCAR-NKT cells, with a primary focus on MM as the disease indication and its corresponding BCMA-targeting AlloCAR-NKT cells, particularly those incorporating IL-15 enhancement (Allo/15BCAR-NKT cells).